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Abstract
The importance of considering confounding due to population stratification in genome-wide
association analysis using case-control designs has been a source of debate. Armitage’st r e n dt e s t ,
t o g e t h e rw i t hs o m eo t h e rm e t h o d sd e v e l o p e df r o mi t ,c a nc o r r e c tf o rp o p u l a t i o ns t r a t i f i c a t i o nt o
some extent. However, there is a question whether the one-sided or the two-sided alternative
hypothesis is appropriate, or to put it another way, whether examining both the one-sided and the
two-sided alternative hypotheses can give more information. The dataset for Problem 1 of Genetic
Analysis Workshop 16 provides us with a chance to address this question. Because it is a part of a
combined sample from the North American Rheumatoid ArthritisC o n s o r t i u m( N A R A C )a n dt h e
Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA), the results from the
combined sample can be used as references. To test this aim, the last 10,000 single-nucleotide
polymorphisms (SNPs) on chromosome 9, which contain the common genetic variant at the TRAF1-
C5 locus, were examined by conducting Armitage’s trend tests. Examining the two-sided alternative
hypothesis shows that SNPs rs12380341 (p =9 . 7×1 0
-11)a n drs872863 (p =1 . 7×1 0
-15), along
w i t hs i xS N P sa c r o s st h eTRAF1-C5 locus, rs1953126, rs10985073, rs881375, rs3761847,
rs10760130,a n drs2900180 (p~1 × 10
-7), are significantly associated with anti-cyclic citrullinated
peptide-positive rheumatoid arthritis. But examining the one-sided alternative hypothesis that the
minor allele is positively associated with the disease shows that only those six SNPs across the
TRAF1-C5 locus are significantly associated with the disease (p~1 × 10
-8), which is consistent with
the results from the combined sample of the NARAC and the EIRA.
Background
The Genetic Analysis Workshop 16 (GAW16) rheuma-
toid arthritis (RA) dataset is the initial batch of whole
genome-wide association study (GWAS) data for the
North American Rheumatoid Arthritis Consortium
(NARAC) cases (N1 = 868) and controls (N0 = 1194)
after removing duplicated and contaminated samples
[1]. The high-throughput genotyping technology [~550 k
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Open Accesssingle-nucleotide polymorphisms (SNPs)] in the NARAC
data makes it a challenge to interpret this GWAS.
One of the disadvantages of the case-control GWAS is
that they are prone to a number of biases including
population stratification [2]. The importance of con-
sidering confounding due to population stratification in
GWAS using case-control designs [3,4] has been a
source of debate. The Armitage’st r e n dt e s t sc a nc o r r e c t
for population stratification to some extent [5-7]; some
other methods based on the Armitage’s trend tests have
also been developed, such as genomic control approach
[8,9]. However, there is still a question as to whether
the one-sided or the two-sided alternative hypothesis is
appropriate, or put it another way, whether examining
both the one-sided and the two-sided alternative
hypotheses can give more information. The dataset for
the Problem 1 of GAW16 provides us with a chance to
address this question. Because it is a part of a combined
sample from the NARAC and the Epidemiological
Investigation of Rheumatoid Arthritis (EIRA), the
results from the combined sample can be used as
references.
To this aim, the last 10,000 SNPs on chromosome 9,
which contains the common genetic variant at the
TRAF1-C5 locus, were examined by conducting Armi-
tage’s trend tests. Two alternative hypotheses, the two-
sided alternative hypothesis that the genotypes at a locus
are associated with the disease and the one-sided
alternative hypothesis that the minor allele at a locus is
positively associated with the disease, were considered.
Three types of scores, co-dominant score, dominant
score, and recessive score, were chosen to construct the
Armitage’s trend tests.
Methods
At any SNP, the data can be summarized in a
contingency table as in Table 1. Always assume that
“M” is the major allele and “m” is the minor allele.
Scores x0, x1,a n dx2, are chosen to construct Armitage’s
trend test. The Armitage’s trend test statistic is defined as
[5,6].
X
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Under the null hypothesis, it is approximately distrib-
uted with χ1
2. This test statistic is suitable for the two-
sided alternative hypothesis that the genotypes at a SNP
are associated with the disease of interest. As discussed in
Armitage [5], whatever the scoring system chosen, the
validity of the test X A
2 is not affected, but the choice of
scoring system affects the power of the test. There are
three common choices of scoring system: 1) co-domi-
nant score: x0 =0 ,x1 =1 ,a n dx2 = 2; 2) dominant score:
x0 =0 ,x1 =1 ,a n dx2 = 1; 3) recessive score: x0 =0 ,x1 =0 ,
and x2 = 1. Here, the names of scoring systems are in
favor of the minor allele “m”.
Fromtherationaleofthegeneticassociationanalysis(see,
for example, Risch and Merikangas [10]), it is more
informative to look at two one-sided alternative hypoth-
eses, i) the alternative that the minor allele is positively
associated with the disease and ii) the alternative that the
major allele is positively associated with the disease.
Furthermore, because the disease of interest is rare, it is
more reasonable to concentrate on the first alternative,
despite that in practice we would do better to consider
both alternatives if no prior information is available on
which allele is positively associated with the disease.
Another reason is that it can reduce the false-positive rate.
Hereafter, we concentrate on the alternative hypothesis
that the minor allele is positively associated with the
disease. To this aim, one-sided can be defined as
Z
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NN N N jx j N jx j
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. 11
10
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Under the null hypothesis, it is approximately distrib-
uted with N(0,1). Similarly, those three scoring systems
c a na l s ob eu s e dh e r e .I ti ss h o w ni nK n a p p[ 1 1 ]t h a ti f
the co-dominant scoring system is chosen, then
ZZ F A =+ /1 ,w h e r eF is the Wright’s coefficient of
inbreeding, and Z is the test statistic simply comparing
the frequencies of minor allele “m” in the case and
control groups. Here the value of F automatically
corrects the population stratification to some extent.
Results
For simplicity of interpretation, we only consider the last
10,000 SNPs on chromosome 9, which contain the
common genetic variant at the TRAF1-C5 locus. The
same analysis can be extended to the whole genome of
approximately 550,000 SNPs.
Table 1: Contingency table at any SNP (M is major allele and m is
minor allele)
Genotype Total
MM Mm Mm
Case n10 n11 n12 N1
Control n00 n01 n02 N0
Total N+0 N+1 N+2 N
Score x0 x1 x2
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are associated with the disease, Table 2 summarizes the
LOD scores (-log10 p) of the test Z
2,w h i c hs i m p l y
compares the frequencies of the minor allele in both
groups, the Armitage’st e s t s X A1
2 with co-dominant
score, X A2
2 with dominant score, X A3
2 with recessive
score, and the Wright’sc o e f f i c i e n to fi n b r e e d i n gF;o n l y
those SNPs with LOD > 6 are reported. The SNPs across
the TRAF1-C5 locus are marked with asterisks.
In Table 2, those six SNPs marked with asterisks have
small F (<0.03), and this explains why their X A1
2 values
in the third column, which correct for population
stratification, are almost the same as Z
2 in the second
column. Also, for these six SNPs, X A1
2 is a bit more
significant than X A2
2 and X A3
2 , and the latter two are
close to each other, which means that these SNPs are
very likely co-dominant. For the other seven SNPs, X A3
2
is a bit more significant than X A1
2 , but X A2
2 is not
significant at all. This shows that these SNPs are very
likely recessive.
Another thing learned from Table 2 is that two SNPs,
rs12380341 and rs872863, have extreme large LOD
scores for Z
2, X A1
2 ,a n d X A3
2 , but surprisingly they
w e r en o tr e p o r t e db yP l e n g ee ta l .[ 1 ] ,w h i c hw a sb a s e d
on the combined sample from the NARAC and the EIRA.
Are these two SNPs truly associated with the disease, or
are they just false positives? Table 3 summarizes the LOD
values for the one-sided alternative that the minor allele
at a SNP is positively associated with the disease.
Similarly, ZA1 is the statistic ZA with co-dominant
score, ZA2 dominant score, and ZA3 recessive score.
From Table 3, only those six SNPs marked with asterisks
are significant for the one-sided alternative that the
minor allele is positively associated with the disease.
These results are completely consistent with the ones in
Plenge et al. [1]. By consider the other one-sided
alternative that the major allele is positively associated
with the disease, the other seven SNPs are significant.
Therefore, as discussed in the preceding section, and
p a r t i c u l a r l yf o rt h i sd a t a s e t ,i ts e e m st h a ti ti sm o r e
reasonable to consider the one-sided alternative that the
minor allele is positively associated with the disease.
Discussion
The question of whether the two-sided alternative or the
one-sided alternatives should be considered is intract-
able, but this manuscript attempts to raise the question
and address it to some extent. Table 3 shows that if we
concentrate on the one-sided alternative that the minor
allele is positively associated with the disease, we get
exactly the same results as Plenge et al. [1]. For rare
diseases, and we have reason to believe that the alleles
positively associated with them have low frequencies in a
general population. Based on this belief (or alternative
hypothesis), it seems that those SNPs without asterisks
are false positives under the two-sided alternative.
But if we do not want to believe that the minor allele is
positively associated with the disease and do not want to
miss any SNPs related to the disease, we had better
consider the two-sided alternative.
Conclusion
More information can be gained from GWAS by using
multiple scoring systems in the Armitage’st r e n dt e s t s
Table 2: LOD values for the two-sided alternative
SNP
a Z
2b X A1
2 c X A2
2 X A3
2 F
d
rs4078292 6.14 5.23 0.91
d 6.96 0.1958
rs12380341 11.61 10.01 0.36 13.45 0.1722
rs16929545 7.22 6.71 1.01 7.62 0.0850
*rs1953126 7.56 7.53 5.05 5.44 0.0037
f
*rs10985073 6.98 6.87 5.63 4.19 0.0173
*rs881375 7.64 7.63 4.81 5.71 0.0020
*rs3761847 7.91 7.75 5.92 5.03 0.0230
*rs10760130 7.42 7.30 6.03 4.40 0.0190
*rs2900180 8.21 8.19 5.20 6.09 0.0022
rs872863 15.65 14.78 1.51 15.11 0.0617
rs888229 6.17 5.27 1.09 6.10 0.1914
rs11185665 7.54 6.48 0.32 9.68 0.1817
rs11792145 8.58 6.53 0.04 12.24 0.3488
aAsterisks indicates SNPs are located on TRAF1-C5.
bZ
2 is the Chi-square test comparing the frequencies of the minor allele
in the two groups.
cSubscripts A1, A2a n dA3 denote test (1) with score systems 1, 2, and 3,
respectively.
dF is the Wright's coefficient of inbreeding.
eBold font indicates X A2
2 is significantly smaller than X A1
2 and X A3
2 .
fItalic font indicates F value is smaller than 0.03.
Table 3: LOD values for the one-sided alternative of the minor
allele
SNP
a Z
b ZA1
c ZA2 ZA3
rs4078292 0.00 0.00 0.03 0.00
rs12380341 0.00 0.00 0.11 0.00
rs16929545 0.00 0.00 0.02 0.00
*rs1953126 7.86 7.83 5.35 5.74
*rs10985073 7.28 7.17 5.93 4.49
*rs881375 7.95 7.93 5.12 6.01
*rs3761847 8.21 8.05 6.22 5.33
*rs10760130 7.72 7.60 6.33 4.70
*rs2900180 8.51 8.49 5.50 6.39
rs872863 0.00 0.00 0.01 0.00
rs888229 0.00 0.00 0.02 0.00
rs11185665 0.00 0.00 0.63 0.00
rs11792145 0.00 0.00 0.27 0.00
aAsterisks indicates SNPs are located on TRAF1-C5.
bZ is the z-test comparing the frequencies of the minor allele in the two
groups.
cSuperscripts A1, A2a n dA3 denote the test (2) with score systems 1, 2,
and 3, respectively.
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alternative hypotheses.
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